JIANGSU HUAYI RADIOPHARMACEUTICALS CO LTD

Overview

JIANGSU HUAYI RADIOPHARMACEUTICALS CO LTD is an active pharmaceutical ingredient (API) supplier with 5 active FDA Type II Drug Master Files, covering DOTATATE ACETATE; GOZETOTIDE FOR RADIOPHARMACEUTICAL PREPARATIONS (PSMA-11); HYDROXY METHYLENE DIPHOSPHONIC ACID; METHYLENEDIPHOSPHONIC ACID RADIOPHARMACEUTICAL PREPARATIONS; PSMA-I&T FOR RADIOPHARMACEUTICAL PREPARATIONS.

API / Drug Master Files

JIANGSU HUAYI RADIOPHARMACEUTICALS CO LTD holds 5 active (5 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• HYDROXY METHYLENE DIPHOSPHONIC ACIDActive2026-02-27
• PSMA-I&T FOR RADIOPHARMACEUTICAL PREPARATIONSActive2026-02-12
• DOTATATE ACETATEActive2025-04-02
• METHYLENEDIPHOSPHONIC ACID RADIOPHARMACEUTICAL PREPARATIONSActive2024-09-16
• GOZETOTIDE FOR RADIOPHARMACEUTICAL PREPARATIONS (PSMA-11)Active2023-10-18

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to JIANGSU HUAYI RADIOPHARMACEUTICALS CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.